The big pharmaceutical companies are targeting Italy: a market that is worth 4.3 billion dollars
De Matthaeis, Labozeta: “Safety, sustainability and quality are the trump cards” ROME, December 2, 2016 – By now the figures are speaking clearly: the multinationals of the pharmaceutical sector are increasingly turning towards Italy, so much so that 10% of pharmaceutical raw materials are now produced in and exported from this country. This is a…